Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does NINTEDANIB Cause Intentional product use issue? 132 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 132 reports of Intentional product use issue have been filed in association with NINTEDANIB. This represents 0.5% of all adverse event reports for NINTEDANIB.

132
Reports of Intentional product use issue with NINTEDANIB
0.5%
of all NINTEDANIB reports
15
Deaths
50
Hospitalizations

How Dangerous Is Intentional product use issue From NINTEDANIB?

Of the 132 reports, 15 (11.4%) resulted in death, 50 (37.9%) required hospitalization, and 2 (1.5%) were considered life-threatening.

Is Intentional product use issue Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for NINTEDANIB. However, 132 reports have been filed with the FAERS database.

What Other Side Effects Does NINTEDANIB Cause?

Diarrhoea (9,103) Nausea (4,198) Dyspnoea (3,080) Decreased appetite (2,832) Death (2,790) Weight decreased (2,628) Vomiting (2,524) Fatigue (2,511) Cough (2,193) Idiopathic pulmonary fibrosis (1,905)

What Other Drugs Cause Intentional product use issue?

INFLIXIMAB (11,028) RITUXIMAB (9,602) INFLIXIMAB-DYYB (7,549) TOCILIZUMAB (5,078) METHOTREXATE (4,087) PREDNISONE (3,961) ABATACEPT (3,693) ADALIMUMAB (3,557) NIVOLUMAB (3,297) LEFLUNOMIDE (3,280)

Which NINTEDANIB Alternatives Have Lower Intentional product use issue Risk?

NINTEDANIB vs NINTEDANIB ESYLATE NINTEDANIB vs NIRAPARIB NINTEDANIB vs NIRMATRELVIR\RITONAVIR NINTEDANIB vs NIROGACESTAT NINTEDANIB vs NIROGACESTAT HYDROBROMIDE

Related Pages

NINTEDANIB Full Profile All Intentional product use issue Reports All Drugs Causing Intentional product use issue NINTEDANIB Demographics